BIOPLUS ACQUISITION CORP shareholders Q3 2022

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 68 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

BIOPLUS ACQUISITION CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$667,0000.86%
Spartan Fund Management Inc. 149,285$1,498,0000.46%
Atalaya Capital Management LP 250,000$2,513,0000.34%
MMCAP International Inc. SPC 400,000$4,020,0000.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,071,051$20,814,0000.29%
Lynwood Capital Management Inc. 25,000$251,0000.27%
ROBINSON CAPITAL MANAGEMENT, LLC 29,972$301,0000.24%
KIM, LLC 500,000$5,018,0000.23%
Saba Capital Management, L.P. 1,791,845$17,981,0000.20%
CANTOR FITZGERALD, L. P. 850,000$8,542,0000.19%
SONA ASSET MANAGEMENT (US) LLC 30,000$301,0000.18%
Taconic Capital Advisors LP 1,000,000$10,050,0000.14%
AQR Arbitrage LLC 623,954$6,252,0000.14%
Starboard Value LP 617,220$6,203,0000.14%
BERKLEY W R CORP 273,860$2,745,0000.13%
Polar Asset Management Partners Inc. 1,056,666$10,619,0000.13%
Shaolin Capital Management LLC 379,302$3,812,0000.10%
Radcliffe Capital Management, L.P. 401,279$4,027,0000.10%
LINDEN ADVISORS LP 1,000,000$10,035,0000.09%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 467,907$4,695,000,0000.09%

This page lists BIOPLUS ACQUISITION CORP's shareholders in Q3 2022. To view BIOPLUS ACQUISITION CORP's shareholder history, click here.